Pfizer sets up drug development centre at Chennai's IIT Research Park

The centre integrates two essential functions under the export-oriented undertaking of Pfizer: Pharmaceutical Sciences (PharmSci) and Global Technology and Engineering (GT&E) Centre of Excellence.

Pfizer has set up a global drug development centre at the IIT Madras Research Park in Chennai.

The company has invested $20 million in the 61,000 square feet research and technology centre at the IIT Madras Research Park. While this centre will be part of a network of 12 global centres set up worldwide, it is the first and only one at present being set up by Pfizer in Asia.

The centre’s capabilities will include the development of both, active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) of differentiated products such as complex/value-added formulations, controlled-release dosage forms, device-combination products, lyophilised injections,